1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends

Global Liver Diseases Therapeutics Market 2015-2019

  • September 2015
  • 95 pages
  • Infiniti Research Limited
Report ID: 3312111

Summary

Table of Contents

Search Inside

About liver diseases
Liver diseases are of different types such as hepatitis, liver cancer, non-alcoholic fatty liver disease, and liver cirrhosis. Hepatitis is the largest segment among these diseases, of which hepatitis C is the biggest and fastest growing segment. The liver diseases caused by viral infections, alcoholism, obesity, diabetes, among many other reasons. Some of the diseases are not curable such as liver cirrhosis or non-alcoholic fatty liver disease, and are usually not diagnosed early. This leads to the substantial damage of the liver, which proves to be life-threatening. Some types of hepatitis are preventable or treatable by using vaccines and indicated drugs.

Technavio's analysts forecast the global liver diseases therapeutics market to grow at a CAGR of 15.61% over the period 2014-2019.

Covered in this report
This report covers the present scenario and the growth prospects of the global liver diseases therapeutics market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various off-label and branded drugs and the expected launch of drug candidates intended to be used in the treatment of liver diseases.

Based on disease indication, the market is segmented as follows:
- Non-alcoholic fatty liver disease (includes non-alcoholic steatohepatitis)
- Liver cirrhosis
- Liver cancer
- Hepatitis (Hepatitis A, B, and C)

This report includes a discussion of the market in the following three regions:
- Americas: The major countries focused in the Americas are the US, Canada, Mexico, and Brazil
- EMEA: The major countries in this region are the UK, Germany, Italy, France, Spain and Middle Eastern and African countries such as Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and the UAE

- APAC: The major countries in this region are Japan, China, Australia, Singapore, South Korea, and India.
Technavio's report, Global Liver Diseases Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the global liver diseases therapeutics market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions
- Americas
- APAC
- EMEA

Key Vendors
- F. Hoffmann-La Roche
- Gilead Sciences
- GlaxoSmithKline
- Johnson & Johnson
- Merck

Other prominent vendors
- AbbVie
- Achillion Pharmaceuticals
- Advinus
- Angion Biomedica
- AstraZeneca
- Bayer
- BiOrion
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Celsion
- Conatus
- Digna Biotech
- Dynavax Technologies
- Eli Lilly
- Galectin Therapeutics
- Genfit
- GenKyoTex
- Isis Pharmaceuticals
- Janssen Pharmaceuticals
- Kaketsuken
- La Jolla Pharmaceutical
- LG Life Sciences
- Mitsubishi Tanabe Pharma
- Nitto Denko
- Novartis
- Onyx Pharmaceuticals
- Phenex Pharmaceuticals
- Promedior
- Promethera Biosciences
- ProMetic Life Sciences
- Raptor Pharmaceuticals
- Shenzhen Kangtai Biological Products
- TCM Biotech
- Tobira Therapeutics
- VBL Therapeutics
- Verva Pharmaceuticals
- Virobay
- Zafgen

Key market driver
- Increased prevalence of liver diseases
- For a full, detailed list, view our report

Key market challenge
- Multiple patent expiries
- For a full, detailed list, view our report

Key market trend
- Growing public awareness
- For a full, detailed list, view our report


Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Ahmad helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation

  • $ 6995
  • Industry report
  • June 2017
  • by GBI Research

Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation Summary Liver plays various vital roles within the body, including the removal of toxins from the blood, the production ...

Global Hepatitis Markers Testing Market 2021: Supplier Shares and Sales Segment Forecasts for 10 Immunodiagnostic and NAT Procedures--Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices

  • $ 6250
  • Industry report
  • July 2017
  • by Venture Planning Group

The report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology ...

Hepatitis A, B, C, D, E Diagnostics Market 2021: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review

  • $ 6250
  • Industry report
  • June 2017
  • by Venture Planning Group

The report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.